Vertex Pharmaceuticals, Inc.

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Biotechnology
GILDGilead Sciences, Inc. 3.27%69.191.0%$1016.06m
BIIBBiogen, Inc. -0.18%336.021.5%$673.86m
AMGNAmgen, Inc. 0.28%222.761.3%$549.92m
ILMNIllumina, Inc. -1.37%296.343.5%$416.23m
REGNRegeneron Pharmaceuticals, Inc. -0.18%398.432.6%$353.76m
VRTXVertex Pharmaceuticals, Inc. 0.84%247.161.9%$345.01m
ALXNAlexion Pharmaceuticals, Inc. -0.22%102.312.0%$216.82m
AAgilent Technologies, Inc. -0.18%84.191.6%$162.97m
EXASEXACT Sciences Corp. -2.20%100.3824.0%$161.18m
SGENSeattle Genetics, Inc. -0.50%117.746.1%$114.18m
INCYIncyte Corp. -0.93%82.002.5%$113.19m
MRNAModerna, Inc. -2.48%18.080.0%$104.12m
XLRNAcceleron Pharma, Inc. -0.40%94.476.1%$93.78m
ALNYAlnylam Pharmaceuticals, Inc. -1.22%131.508.7%$93.28m
BMRNBioMarin Pharmaceutical, Inc. 4.60%93.794.3%$92.97m

Company Profile

Vertex Pharmaceuticals, Inc. engages in the business of discovering, developing, manufacturing and commercializing small molecule drugs for patients with serious diseases. It focuses on development and commercializing therapies for the treatment of cystic fibrosis, infectious diseases including viral infections such as influenza and bacterial infections, autoimmune diseases such as rheumatoid arthritis, cancer, inflammatory bowel disease and neurological disorders including pain and multiple sclerosis. The company was founded by Joshua S. Boger in 1989 and is headquartered in Boston, MA.